Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 4
2011 2
2012 3
2013 1
2014 2
2015 2
2022 1
2023 1
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity.
Vennin C, Cattaneo CM, Bosch L, Vegna S, Ma X, Damstra HGJ, Martinovic M, Tsouri E, Ilic M, Azarang L, van Weering JRT, Pulver E, Zeeman AL, Schelfhorst T, Lohuis JO, Rios AC, Dekkers JF, Akkari L, Menezes R, Medema R, Baglio SR, Akhmanova A, Linn SC, Lemeer S, Pegtel DM, Voest EE, van Rheenen J. Vennin C, et al. Among authors: baglio sr. Cancer Cell. 2023 Jun 12;41(6):1170-1185.e12. doi: 10.1016/j.ccell.2023.05.009. Cancer Cell. 2023. PMID: 37311414 Free article.
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.
Verkleij CPM, O'Neill CA, Broekmans MEC, Frerichs KA, Bruins WSC, Duetz C, Kruyswijk S, Baglio SR, Skerget S, Montes de Oca R, Zweegman S, Verona RI, Mutis T, van de Donk NWCJ. Verkleij CPM, et al. Among authors: baglio sr. Clin Cancer Res. 2024 Jul 15;30(14):3006-3022. doi: 10.1158/1078-0432.CCR-23-3333. Clin Cancer Res. 2024. PMID: 38687588
Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell Development.
Massaro C, Sensoy HN, Mulders M, De Schrijver C, Gómez-Martín C, Simon Nieto J, Lagerweij T, Atmopawiro A, Pérez-Boza J, Bebelman M, Bosch L, Foderaro S, Neves Ferreira M, van Eijndhoven MAJ, van Weering JRT, Dell'Aversana C, Altucci L, Savci-Heijink CD, van de Donk NWCJ, Giorgio C, Brandolini L, Allegretti M, Pegtel DM, Baglio SR. Massaro C, et al. Clin Cancer Res. 2024 Oct 15;30(20):4714-4728. doi: 10.1158/1078-0432.CCR-23-4097. Clin Cancer Res. 2024. PMID: 39115426
T-cell redirecting bispecific antibody treatment in multiple myeloma: current knowledge and future strategies for sustained T-cell engagement.
Heerma van Voss MR, Molenaar RJ, Korst CLBM, Bartelink IH, Baglio SR, Kruyswijk S, de Ruijter M, Zweegman S, Kuipers MT, van de Donk NWCJ. Heerma van Voss MR, et al. Among authors: baglio sr. Expert Opin Biol Ther. 2024 Sep;24(9):889-901. doi: 10.1080/14712598.2024.2397436. Epub 2024 Sep 1. Expert Opin Biol Ther. 2024. PMID: 39185748 Free article. Review.
19 results